Search research articles
Contact Us
Filters
Showing results (401-410 of 2,203) with videos related to
Page
of 221
Sort By:
Patient Preference and Adherence
|
February 6, 2018
Barriers to treatment: describing them from a different perspective
Francesca Devine, Taylor Edwards, Steven R Feldman
Expert Review of Clinical Immunology
|
September 22, 2022
Treatment strategies, including antibiotics, to target the immune component of rosacea
Kristen Delans, Katherine Kelly, Steven R Feldman
International Journal of Clinical Practice. Supplement
|
February 9, 2000
Sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction: analysis of two flexible dose-escalation studies. Sildenafil Study Group
R Feldman, E J Meuleman, W Steers
Journal of Health Economics
|
April 8, 1995
The effect of market structure on HMO premiums
D Wholey, R Feldman, J B Christianson
Journal of the American Academy of Dermatology
|
November 21, 2009
Microscopically differentiating dermatophytes from sock fibers
Abraar Karan, Ali Alikhan, Steven R Feldman
Expert Opinion on Biological Therapy
|
January 19, 2010
Psoriasis and its treatment with adalimumab
Ala Iaconi, Steven R Feldman, Rajesh Balkrishnan
Journal of the American Academy of Dermatology
|
April 25, 2000
Clearance is not a realistic expectation of psoriasis treatment
S N Al-Suwaidan, S R Feldman
Journal of the American Academy of Dermatology
|
May 29, 2000
Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
S R Feldman, N Sangha, V Setaluri
The Annals of Pharmacotherapy
|
December 26, 2025
Lebrikizumab-lbkz for the Treatment of Atopic Dermatitis: A Drug Review
Danial Nasim, Brett Shaffer, Steven R Feldman
Journal of Drugs in Dermatology : JDD
|
April 3, 2013
Infections associated with the use of tumor necrosis factor-α inhibitors in psoriasis
Xi Tan, Rajesh Balkrishnan, Steven R Feldman
Page
of 221
Search research articles
Search
Showing results (401-410 of 2,203) with videos related to
Sort By:
Page
of 221
Patient Preference and Adherence
|
February 6, 2018
Barriers to treatment: describing them from a different perspective
Francesca Devine, Taylor Edwards, Steven R Feldman
Expert Review of Clinical Immunology
|
September 22, 2022
Treatment strategies, including antibiotics, to target the immune component of rosacea
Kristen Delans, Katherine Kelly, Steven R Feldman
International Journal of Clinical Practice. Supplement
|
February 9, 2000
Sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction: analysis of two flexible dose-escalation studies. Sildenafil Study Group
R Feldman, E J Meuleman, W Steers
Journal of Health Economics
|
April 8, 1995
The effect of market structure on HMO premiums
D Wholey, R Feldman, J B Christianson
Journal of the American Academy of Dermatology
|
November 21, 2009
Microscopically differentiating dermatophytes from sock fibers
Abraar Karan, Ali Alikhan, Steven R Feldman
Expert Opinion on Biological Therapy
|
January 19, 2010
Psoriasis and its treatment with adalimumab
Ala Iaconi, Steven R Feldman, Rajesh Balkrishnan
Journal of the American Academy of Dermatology
|
April 25, 2000
Clearance is not a realistic expectation of psoriasis treatment
S N Al-Suwaidan, S R Feldman
Journal of the American Academy of Dermatology
|
May 29, 2000
Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
S R Feldman, N Sangha, V Setaluri
The Annals of Pharmacotherapy
|
December 26, 2025
Lebrikizumab-lbkz for the Treatment of Atopic Dermatitis: A Drug Review
Danial Nasim, Brett Shaffer, Steven R Feldman
Journal of Drugs in Dermatology : JDD
|
April 3, 2013
Infections associated with the use of tumor necrosis factor-α inhibitors in psoriasis
Xi Tan, Rajesh Balkrishnan, Steven R Feldman
Page
of 221